Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
<strong>IMS</strong> COM PANY PRO FILES NOVARTIS SUBSIDIARY LISTING<br />
LEK<br />
Full Name: Lek Pharma s. r. o.<br />
Street Ad dress: Jeseniova 30, 130 00 Praha 3<br />
Tel: +420 2 21421611/21421613<br />
Fax: +420 2 21421629/21421630<br />
Email: lekcz@lekpharma.anet.cz<br />
De scrip tion: Rep re sen ta tive of fice.<br />
Con tacts (Pharm): Chair man: Joze Kavticnik;<br />
Gen eral Con tact: Joze Kavticnik<br />
NOVARTIS<br />
Full Name: Novartis s.r.o.<br />
Street Ad dress: Nagano III., U Nakladoveho<br />
nadrazi 10, 130 00 Praha<br />
Tel: +420 2 25775111<br />
Fax: +420 2 25775222<br />
Home Page: www.novartis.cz<br />
De scrip tion: De vel oper, pro moter,<br />
sales/detailer. Prod uct ranges in clude: phar ma -<br />
ceu ti cal prod ucts (branded, unbranded, pre scrip -<br />
tion, non-pre scrip tion), hos pi tal pharmaceuticals,<br />
oph thal mic prod ucts, vet er i nary pharmaceuticals.<br />
Es tab lished 1996. Di vi sions in clude: Novartis<br />
Consumer Health.<br />
Con tacts (Pharm): Chair man: Roger Meij;<br />
Com mer cial Op er a tions: Pavel Kral; Mar ket Re -<br />
search: Lenka Rysava; Gen eral Con tact: Iveta<br />
Kotaskova<br />
Sub sid iary of: Novartis, Swit zer land (100%)<br />
Phar ma ceu ti cal Sales: US$ 95-100 mil lion<br />
Prod ucts (% of Sales by Lead ing 5): 50-55%<br />
Ther a peu tic Classes (% of Sales by Lead ing<br />
5): 55-60%<br />
Dose Forms (% of Sales by Lead ing 5):<br />
95-100%<br />
Prin ci pal Prod ucts:<br />
GLIVEC (antineoplastic other)<br />
FEMARA (cytostatic hor mone an tag o nist)<br />
GLYVENOL (var i cose ther apy sys temic)<br />
FORADIL (B2-stim u lant)<br />
SANDIMMUN NEORAL (immunosuppressive<br />
agent)<br />
Ther a peu tic Range:<br />
antineoplastics 23%<br />
cytostatic hor mone ther apy 11%<br />
antiasthma and COPD prod ucts 10%<br />
antivaricosis/antihemorrhoidal prep a ra tions<br />
9%<br />
immunosuppressive agents 6%<br />
Lead ing Dose Forms:<br />
coated tab lets 46%<br />
cap sules 29%<br />
tab lets 9%<br />
in fu sions 8%<br />
liq uids 5%<br />
SANDOZ<br />
Full Name: Sandoz s.r.o.<br />
Street Ad dress: Jeseniova 30, 130 00 Praha 3<br />
Tel: +420 2 21421611<br />
Fax: +420 2 21421629<br />
Sub sid iary of: Novartis, Swit zer land (100%)<br />
Phar ma ceu ti cal Sales: US$ 75-80 mil lion<br />
Prod ucts (% of Sales by Lead ing 5): 40-45%<br />
Ther a peu tic Classes (% of Sales by Lead ing<br />
5): 60-65%<br />
Dose Forms (% of Sales by Lead ing 5):<br />
95-100%<br />
Prin ci pal Prod ucts:<br />
AMOKSIKLAV (pen i cil lin broad spec trum)<br />
TU LIP (cho les terol/triglyceride reg u lat ing prep a -<br />
ra tion)<br />
GINGIO (ce re bral/pe riph eral vasotherapeutic)<br />
ACC LONG (ex pec to rant)<br />
PIRAMIL (ACE in hib i tor plain)<br />
Ther a peu tic Range:<br />
antibacterials sys temic 32%<br />
lipid-reg u lat ing/antiatheroma prep a ra tions<br />
10%<br />
ce re bral/pe riph eral vasotherapeutics 9%<br />
cough and cold prep a ra tions 7%<br />
renin-an gio ten sin sys tem agents 6%<br />
Lead ing Dose Forms:<br />
coated tab lets 39%<br />
tab lets 29%<br />
vi als 15%<br />
cap sules 8%<br />
am poules 5%<br />
DENMARK<br />
HEXAL<br />
Full Name: Hexal A/S<br />
Street Ad dress: Kanalholmen 8-12, DK-2650<br />
Hvidovre<br />
Tel: +45 38 34 42 42<br />
Fax: +45 38 34 11 23<br />
Email: info@hexal.dk<br />
Home Page: www.hexal.dk<br />
De scrip tion: De vel oper, man u fac turer, ex -<br />
porter, dis trib u tor, sales/detailer. Pro motes,<br />
sells/de tails for other com pa nies. Prod uct ranges<br />
in clude: phar ma ceu ti cal prod ucts (non-pre scrip -<br />
© 2009 <strong>IMS</strong> Health In cor po rated or its af fil i ates Page 161
Change language